Related and Nonrelated Parties [Axis]
Related Party [Member]
Nonrelated Party [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Debt Instrument [Axis]
Convertible Promissory Note [Member]
Investment, Name [Axis]
Jeffrey Wang
DNA Holdings Ventures Inc [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Legal Entity [Axis]
DNA X LLC [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Asset Class [Axis]
Money Market Funds [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Streeterville Capital LLC [Member]
Disposal Group Classification [Axis]
Discontinued Operations [Member]
Disposal Group Name [Axis]
Pace Car Acquisition L L C [Member]
Pace Car Acquisitions L L C [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Asset Purchase Agreement [Member]
Measurement Input Type [Axis]
Measurement Input, Commodity Market Price [Member]
Measurement Input, Share Price [Member]
Measurement Input, Maturity [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Purchase Agreement
The February Note
Scenario [Axis]
Major Trigger Event
Minor Trigger Event
July Purchase Agreement
July Note
Membership Interest Purchase Agreement [Member]
Plan Name [Axis]
ChEF Purchase Agreement
Sale of Stock [Axis]
Public Offering
Placement Agent Warrants [Member]
Financial Instrument [Axis]
Warrant [Member]
Title and Position [Axis]
Investor One
Investor Two
Sales Agreement [Member]
Preferred Stock [Member]
Location, Statement of Income, Balance [Axis]
Award Type [Axis]
Unvested Stock Options [Member]
Restricted Stock Units (RSUs) [Member]
Geographical [Axis]
UNITED STATES
Antidilutive Securities [Axis]
Shares Subject To Options To Purchase Common Stock [Member]
Unvested Restricted Stock Units [Member]
Shares Subject To Warrants To Purchase Common Stock [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Assets
Cash and cash equivalents
Receivable for cash held back from the asset sale
Prepaid expenses and other current assets
Current assets held for sale
Total Current assets
Investment in DNA X LLC under equity method
Deferred tax assets
Other assets
Non-current assets held for sale
Total assets
Liabilities and stockholders’ deficit
Accounts payable
Accrued liabilities
Promissory notes, net
Derivative liability
Income tax payable
Current liabilities held for sale
Total current liabilities
Deferred tax liability
Total liabilities
Commitments and contingencies (Note 9)
Redeemable common stock; $0.001 par value; 223,201 shares issued and outstanding; redemption value $900 at March 31, 2026 and $1,228 as of December 31, 2025 (Note 6)
Stockholders’ deficit
Common stock, $0.001 par value per share; 1,000,000,000 shares authorized: and 1,265,067 shares issued and outstanding at both March 31, 2026 and December 31, 2025
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized: and no shares issued and outstanding at March 31, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Total stockholders’ deficit
Total liabilities, redeemable common stock, and stockholders’ deficit
Statement of Financial Position [Abstract]
Temporary equity, par value
Tempoary equity, shares issued
Temporary equity, shares outstanding
Redemption value
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Reverse stock split
Income Statement [Abstract]
Net revenues
Operating expenses
General and administrative
Total operating expenses
Net loss from operations
Interest expense, net
Loss on remeasurement of derivative liability
Equity income from DNA X LLC
Net loss from continuing operations before income taxes
Income tax expense from continuing operations
Net loss from continuing operations
Discontinued Operations:
Income from discontinued operations, net of tax
Net income
Net earnings (loss) per share basic and diluted:
Net loss per share basic, Continuing operations
Net loss per share diluted, Continuing operations
Net loss per share basic, Discontinued operations
Net loss per share diluted, Discontinued operations
Net loss per share basic, Net loss
Net loss per share diluted, Net loss
Weighted-average shares used in computing net loss per share:
Weighted-average shares used in computing net loss per share, basic
Weighted-average shares used in computing net loss per share, diluted
Statement [Table]
Statement [Line Items]
Beginning balance, value
Balance, shares
Issuance of common stock upon exercise of stock options and settlement of restricted stock units, net of taxes withheld
Balance, shares
Issuance of common stock, net of issuance costs
Balance, shares
Stock-based compensation
Net income
Remeasurement of redemption value of redeemable common stock
Ending balance, value
Balance, shares
Statement of Stockholders' Equity [Abstract]
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on sale of assets, net assets transferred
Depreciation and amortization
Amortization of debt discount and issuance costs
Stock-based compensation ($211 from continuing and $93 from discontinued operations for 2026 and all from discontinued operations for 2025-see Note 7)
Loss on remeasurement of derivative liability
Release of customer allowance liability
Investment income from DNA X LLC under the equity method
Other
Changes in operating assets and liabilities:
Accounts receivable
Non-trade receivable
Inventory
Prepaid expenses and other current assets
Contract fulfilment assets
Other assets
Accounts payable
Accrued liabilities
Deferred tax assets
Deferred tax liabilities
Income tax payable
Net cash used in operating activities
Cash flows from investing activities:
Net cash received from sale of assets
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs
Proceeds from promissory note, net of issuance costs
Proceeds from short-term borrowings
Net cash provided by financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash activities:
Repayment of notes payable from proceeds of asset sale
Receivable for cash held back from asset sale
Stock-based compensation continuing operations
Stock-based compensation discontinued operations
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
The Company and Its Significant Accounting Policies
Revenue from Contract with Customer [Abstract]
Revenue Recognition
Fair Value Disclosures [Abstract]
Fair value measurement
Discontinued Operations and Disposal Groups [Abstract]
Closing of the Asset Sale
Debt Disclosure [Abstract]
Promissory Notes
Equity [Abstract]
Stockholders’ Deficit
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Earnings Per Share [Abstract]
Net Income (Loss) Per Share
Segment Reporting [Abstract]
Entity Level Information
Subsequent Events [Abstract]
Subsequent Events
Description of Business
Liquidity and Ability to Continue as a Going Concern
Reverse Stock Split
Financial Statement Presentation
Principles of Consolidation
Reclassifications
Assets Held For Sale
Discontinued Operations
Estimates
Concentrations of Credit Risk
Segment Information
Cash and Cash Equivalents
Receivable
Receivables Financing Agreement
Inventory
Property and Equipment
Variable Interest Entities
Equity Method Investments
Leases
Non-recurring Engineering (“NRE”) Tooling and Purchased Software Licenses
Long-lived Assets
Revenue Recognition
Cost of Revenues
Advertising
Research and Development
Stock-Based Compensation
Comprehensive Income or Loss
Income taxes
Net Earnings (Loss) per Share
Promissory Notes
Derivative Liability—
Recent Accounting Pronouncements
Schedule of Fair Value Assets
Schedule Of Discontinued Operations
Schedule of Components of Net Carrying Amount
Schedule of Fair Value Derivative Liability
Schedule of Interest Expense
Schedule of Stock Based Compensation Expense
Schedule of Stock Option Activity
Schedule of Outstanding Restricted Stock Units
Schedule of Warrant Activity
Schedule of Computation of Basic and Diluted Net Loss Per Share
Schedule of Dilutive Common Shares were Excluded from Calculation of Diluted
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Date of incorporation
Principal balance
Proceeds from the sale of the convertible note
Extinguishment of debt amount
Accrued unpaid interest
Membership interests
Capitalized Contract Cost, Net
Repayment of the convertible note
Foreign cash and cash equivalents at carrying value
Original amount
Equity method investment voting interests percentage
Other income expense
Advertising expense
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Money market funds *
Derivative liability – conversion feature on note
Disposal Groups, Including Discontinued Operations [Table]
Disposal Group, Including Discontinued Operations [Line Items]
Purchase price
Working capital
Cash
Debt
liabilities
Cash
Gain on sale of assets
Related tax expenses
Gsin on sale of assets
Accounts receivable, net
Non-trade receivables
Inventory
Prepaid expenses and other current assets
Total current assets held for sale
Property and equipment, net
Contract fulfilment assets
Other assets
Total non-current assets held for sale
Total assets held for sale
Accounts payable
Accrued liabilities
Total liabilities held for sale
Net revenues
Cost of revenues
Gross profit (loss)
Research and development
Sales and marketing
General and administrative
Total operating expenses
Net income (loss) from operations
Gain on sale of assets
Other income
Income before income tax expense
Income tax expense
Net income from discontinued operations
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Gain on sale of assets, net assets transferred
Non-trade receivable
Inventory
Contract fulfillment assets
Net cash provided by (used in) operating activities from discontinued operations
Net cash provided by investing activities from discontinued operations
Net cash received from asset sale
Principal
Less: unamortized debt discount
Long term debt
Current portion
Beginning balance (January 1)
Fair value adjustment
Ending value (March 31)
Contractual interest expense
Amortization of debt discount
Amortization of debt issuance costs
Interest expense
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Convertble notes issued
Interest rate percentage
Interest rate percentage, default
Initial conversion price of convertible note
Covertible note terms, description
Effective interest rate
Derivative liability
Loss on the revaluation of the derivative liability
Derivative liability, measurement input
Convertible note payment terms
Total payoff
Principal amount
Original issue discount
Payments for legal fees
Principal amount
Issuance costs
Interest rate
Outstanding percentage
Debt instrument redemption amount
Outstanding percentage
Purchase price
Issuance cost
Accrues interest rate
Debt instrument description
Payment of interest
Accrued interest
Accounts receivable
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Capital stock par value
Shares issued on acquisitions
Redeemable common stock
Right to appoint board of directors description
Membership interest description
Investment in DNA X, LLC
Stock price
Charged to retained deficit
Stock issued during period, value
Common stock par value
Shares of common stock
Shares issued price per share
Cash fee percentage
Legal fees
Warrants issued
Warrant exercise price
Warrants
Warrants adjustment description
Net proceeds
Issuance costs
Beneficiary ownership limitation percentage
Commission rate
Proceeds from common stock
Other expenses
Preferred shares par value
Price per share exercisable
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expenses
Options, Outstanding, Beginning balance
Weighted average exercise price per share, Outstanding, Beginning balance
Options, Granted
Weighted average exercise price per share, Granted
Options, Forfeited
Options Forfeited, Weighted average exercise price per share
Options, Forfeited and Expired
Weighted average exercise price per share, Forfeited and Expired
Options, Outstanding, Beginning balance
Weighted average exercise price per share, Outstanding, Beginning balance
Outstanding, Weighted average remaining contractual life (in years)
Outstanding, Aggregate Intrinsic Value, Beginning Balance
Options, Vested and expected to vest
Weighted average exercise price per share, Vested and expected to vest
Weighted average remaining contractual life, Vested and expected to vest
Aggregate Intrinsic Value, Vested and expected to vest
Option, Exercisable
Weighted average exercise price per share, Exercisable
Weighted average remaining contractual life (in years), Exercisable
Aggregate Intrinsic Value, Exercisable
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding at January 1, 2026
Granted
Released
Forfeited
Outstanding at March 31, 2026
CompensationRelatedCostsSharebasedPaymentsTable [Table]
Number of warrants outstanding, Beginning balance
Number of warrants outstanding, Granted
Number of warrants outstanding, Forfeited
Weighted average exercise price per share, Forfeited
Number of warrants outstanding, Expired
Weighted average exercise price per share, Expired
Number of warrants outstanding, Ending balance
Number of warrants outstanding, Exerciseable
Weighted average exercise price per share, Exerciseable
Stock-based compensation, unamortized
Unamortized stock-based compensation cost, weighted average period of recognition
IncomeTaxDisclosureTable [Table]
Income tax expense
Deferred tax expense
Effective Income Tax Rate Reconciliation, Percent
Operating loss carryforward
Unrecognized tax benefits
Payments for royalties
Indemnification value
Loss from continuing operations
Net income from discontinued operations
Earnings (loss) per share basic, continuing operations
Earnings (loss) per share diluted,continuing operations
Earnings (loss) per share basic, discontinuing operations
Earnings (loss) per share diluted, discontinuing operations
Net earnings per share, basic
Net earnings per share, diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Subsequent Event [Table]
Subsequent Event [Line Items]
Principal balance
Proceeds from convertible debt
Description ofdebt default event of default
Debt instrument, maturity date
Investment in dna XLlc.
Income tax expense from continuing operations.
Stock issued during period value restricted of units.
Stock issued during period shares restricted of units.
Release of customer allowance liability.
Increase decrease in non trade receivable.
Increase decrease in contract fulfillment assets.
Gain on sale of assets, net of cash
Investment income from DNA X LLC
Cash receive from asset sale
Liquidity And Ability To Continue As Going Concern [Policy Text Block]
Reverse Stock Split [Policy Text Block]
Related Party Transactions [Policy Text Block]
Jeffrey Wang [Member]
Foreign cash and cash equivalents at carrying value.
Receivables Financing Agreement [Policy Text Block]
Equity method investment voting interests percentage
Non Recurring Engineering Tooling And Purchased Software Licenses Policy [Policy Text Block]
Money market funds fair value disclosure.
Derivative liability conversion feature.
The February Note
Working capital
Disposal group nontrade receivables current.
Disposal group related party receivable.
Disposal group contract fulfillment assets.
Disposal group including discontinued operation revenue excluding related party.
Disposal group including discontinued operation research and development.
Disposal group including discontinued operation sales and marketing.
Disposal group including discontinued operation operating expenses.
Discontinued operation income loss from discontinued operation net income loss from operations
DiscontinuedOperationIncomeLossFromDiscontinuedOperationGainOnSaleOfAssets
Discontinued operation income loss from other income expense
Increase decrease in non trade receivables.
Cash received from asset sale
DNA Holdings Ventures Inc [Member]
Debt instrument interest rate stated percentage in caseof default.
Purchase Agreement [Member]
Debt instrument outstanding percentage.
Debt instrument redemption amount.
Major Trigger Event [Member]
Minor Trigger Event [Member]
July Purchase Agreement
July Note
Accrues interest rate.
DNA X LLC [Member]
Membership Interest Purchase Agreement [Member]
Right to appoint board of directors description.
Membership interest description.
ChEF Purchase Agreement
Public Offering [Member]
Percentage of cash fee.
Placement Agent Warrants [Member]
Warrants adjustment, description.
Beneficiary ownership limitation percentage.
Investor One
Investor Two
Sale of stock commission percentage.
Sales Agreement [Member]
Income loss from discontinuing operations.
Research And Development Expenses [Member]
Payments for cash
Unvested Stock Options [Member]
Description Of Business [Policy Text Block]
Indemnification value.
Effective income tax rate continuing operation.
Capital stock par value.
Deferred tax liability.
Deferred tax assets.
Repayment of notes payable from proceeds of asset sale.
Receivable for cash held back from asset sale.
Streeterville Capital LLC [Member]
Discontinued operation income loss from other income.
Securities Purchase Agreement [Member]
Assets, Current
Assets [Default Label]
Liabilities, Current
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
IncomeTaxExpenseFromContinuingOperations
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Shares, Outstanding
Derivative, Loss on Derivative
InvestmentIncomeFromDnaXLlc
Other Noncash Income (Expense)
Increase (Decrease) in Accounts Receivable
IncreaseDecreaseInNonTradeReceivable
Increase (Decrease) in Other Receivables
Increase (Decrease) in Prepaid Expense and Other Assets
IncreaseDecreaseInContractFulfilmentAssets
Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
IncreaseDecreaseInDeferredTaxAssets
Increase (Decrease) in Income Taxes Payable
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Revenue [Policy Text Block]
Share-Based Payment Arrangement [Policy Text Block]
Policy Loans Receivable, Policy [Policy Text Block]
Cash [Default Label]
Disposal Group, Including Discontinued Operation, Inventory, Current
Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current
Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent
Disposal Group, Including Discontinued Operation, Assets
Disposal Group, Including Discontinued Operation, Accounts Payable, Current
Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current
DisposalGroupIncludingDiscontinuedOperationRevenueExcludingRelatedParty
Disposal Group, Including Discontinued Operation, General and Administrative Expense
DiscontinuedOperationIncomeLossFromDiscontinuedOperationGainOnSaleOfAssets
Depreciation, Depletion and Amortization
IncreaseDecreaseInNonTradeReceivables
Increase (Decrease) in Inventories
IncreaseDecreaseInContractFulfillmentAssets
CashReceivedFromAssetSale
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Long-Term Debt
Derivative Liability
Interest Expense, Operating and Nonoperating
Debt Instrument, Redemption Price, Percentage
Proceeds from Issuance of Debt
Payments of Stock Issuance Costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePriceExerciseable
Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Percent
IncomeLossFromDisContinuingOperations